Loading...
554 China Pharmaceuticals Reports
Country Covered: China
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, Novo Nordisk
Country Covered: China
Study Period: 2019 - 2029
Major Players: WuXi AppTec (WuXi STA), Asymchem Laboratories, Reyoung Pharmaceutical, Zhejiang NHU Co., Ltd., CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd)
Country Covered: China
Study Period: 2019 - 2029
Major Players: F Hoffmann-La Roche AG, Zhongyuan Union Stem Cell Bioengineering, Amoy Diagnostics, New Horizon Health Ltd, Berry Genomics
Country Covered: China
Study Period: 2019 - 2029
Major Players: Merck & Co. Inc., Bayer AG, Amgen Inc, AstraZeneca, Johnson & Johnson Services, Inc.
Country Covered: China
Study Period: 2019 - 2029
Major Players: B. Braun Melsungen AG, Nutricia, Abbott, Nestlé, Baxter
Country Covered: China
Study Period: 2019 - 2029
Major Players: AbbVie Inc, Aspen Holdings, Baxter International, Fresenius SE & Co. KGaA, B. Braun SE
Country Covered: China
Study Period: 2019 - 2029
Major Players: Stryker Corporation, Zimmer Biomet Holdings Inc, CONMED Corporation, Arthrex Inc, Medtronic PLC
Country Covered: China
Study Period: 2021 - 2029
Major Players: Cook Group Incorporated, Integra LifeSciences Corporation, Medtronic PLC, Smith & Nephew plc (Osiris Therapeutics), AbbVie (Allergan plc)
Country Covered: China
Study Period: 2019 - 2029
Major Players: Boehringer Ingelheim International GmbH, Procter & Gamble, Sanofi SA, Dr. Reddy's Laboratories, Taisho Pharmaceutical Group
Country Covered: China
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee
Country Covered: China
Study Period: 2019-2029
Major Players: Glaxosmithkline Plc, Bristol-Myers Squibb, Sanofi, Eli Lilly, AstraZeneca Plc
Country Covered: China
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb
Country Covered: China
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.
Country Covered: China
Study Period: 2018 - 2029
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: China
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb
Country Covered: China
Study Period: 2019 - 2029
Major Players: AbbVie Inc., Pfizer Inc., Teva Pharmaceutical, Sun Pharmaceutical Industries Ltd, Novartis AG
Country Covered: China
Study Period: 2019 - 2029
Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis
Country Covered: China
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon
Country Covered: China
Study Period: 2018 - 2029
Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark
Country Covered: China
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen
Country Covered: China
Study Period: 2019 - 2029
Major Players: Smith+Nephew, Integra LifeSciences, Convatec Inc., Mölnlycke Health Care AB, 3M
Country Covered: China
Study Period: 2019 - 2029
Major Players: Fresenius SE & Co. KGaA, Pacira Pharmaceuticals, Inc., Pfizer Inc., Septodont, Baxter International Inc.
Country Covered: China
Study Period: 2019 - 2029
Major Players: AstraZeneca PLC, Bayer AG, F. Hoffmann La-Roche Ltd, Teva Pharmaceutical Industries Ltd, Seagen Inc
Country Covered: China
Study Period: 2021 - 2029
Major Players: Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Merck & Co, Inc., GlaxoSmithKline plc (ViiV Healthcare)
Country Covered: China
Study Period: 2019 - 2029
Major Players: AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Merck KGaA, Johnson and Johnson, Pfizer, Inc.
Country Covered: China
Study Period: 2019 - 2029
Major Players: Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, SymBio Pharmaceuticals Limited, Genmab AS
Country Covered: China
Study Period: 2019 - 2029
Major Players: Johnson & Johnson (Janssen Pharmaceuticals Inc.), Novartis AG, Bristol Myers Squibb Company, Merck & Co. Inc, F. Hoffmann-La Roche Ltd
Country Covered: China
Study Period: 2019 - 2029
Major Players: Bristol Myers Squibb, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, GlaxoSmithKline (GSK) PLC
Country Covered: China
Study Period: 2019 - 2029
Major Players: Bayer AG, Cipla Inc., Pfizer Inc, GlaxoSmithKline Plc, Shionogi & Co., Ltd
Country Covered: China
Study Period: 2021 - 2029
Major Players: Johnson and Johnson, Perrigo Company Plc, Bayer AG, Sanofi, Pfizer